Taiwan Terry Lin, general manager, and Freia Wei, director for international business at UniPharma, on the company’s move from specialty distribution to drug development and diagnostic products. With an upcoming IPO, UniPharma is considering both organic and inorganic development opportunities to further nurture its geographical expansion. Being one of the best-established…
Unipharm You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing on board? Many of my friends and colleagues were surprised and asked me what the reason is for my move…
See our Cookie Privacy Policy Here